Advertisement
Screener

NeuroSense Therapeutics Ltd. (NRSN) Form 6-K: Report of foreign private issuer, 2021

NeuroSense Therapeutics Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2021-12-13: Form 6-K; Period of report 2021-12-13; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea152202-6k_neurosense.htm.
FiledFormPeriod of reportDescriptionDocument
2021-12-136-K2021-12-13REPORT OF FOREIGN PRIVATE ISSUERea152202-6k_neurosense.htm